Skip to content

Author

Guilin Meng

We have 1 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Single-nucleus transcriptomics-based drug screening platform for focal cortical dysplasia.

A transcriptome-guided framework for linking multicellular disease signatures to candidate therapeutic strategies in refractory epilepsy is established, and four compounds reduced seizure-like activity in vivo, as assessed by behavioral assays and local field potential recordings.

Chuantao Fang, Guilin Meng, Lin Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.